Literature DB >> 15515012

Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer.

Brett G Masasyesva1, Betty C Tong, Malcolm V Brock, Thomas Pilkington, David Goldenberg, David Sidransky, Susan Harden, William H Westra, Joseph Califano.   

Abstract

Sublobar resection for early-stage lung cancer has been used for patients who are not candidates for lobar resection. However, sublobar resection is associated with high local recurrence rates in the context of tumor-free parenchymal margins. The mechanism underlying this high recurrence rate is not well understood. We hypothesized that this elevated risk of local recurrence is due to undetected tumor cells present at parenchymal margins thought to be negative by conventional light microscopy. Thirteen of 44 patients who underwent sublobar resection for lung cancer were found to have a k-ras mutation at codon 12.1. A novel fluorescence-based assay for detection of rare copies of mutant DNA in a background of wild-type DNA, fluorescent gap ligase chain reaction, was used to quantitate the mutant/wild-type DNA in a range of 1 to 1/10,000 in histologically normal margins from these resections. Nine of 13 patients had at least one margin with the number of mutant cells over or equal to a threshold of 1/5,000, and of these, 6/9 (67%) recurred locally. None of the remaining 4 patients without mutant DNA in any surgical margin had evidence of recurrence. The higher rate of local recurrence associated with sublobar resection of lung cancer is likely due to the occult presence of tumor cells at resection margins. These occult tumor cells can be quantitated using a novel fluorescence-based assay and define a group of patients at high risk for local recurrence who are candidates for adjuvant therapy or more extensive resection. This methodology may be adaptable to a real-time format for intraoperative use. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15515012     DOI: 10.1002/ijc.20683

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Hajime Maeda; Akihide Matsumura; Mitsunori Ohta; Meinoshin Okumura
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.

Authors:  J Kim; H A Reber; S M Dry; D Elashoff; S L Chen; N Umetani; M Kitago; O J Hines; K K Kazanjian; S Hiramatsu; A J Bilchik; S Yong; M Shoup; D S B Hoon
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

Review 3.  Locoregional recurrence after pulmonary sublobar resection of non-small cell lung cancer: can it be reduced by considering cancer cells at the surgical margin?

Authors:  Noriyoshi Sawabata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-29

4.  Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.

Authors:  Stacey R Oppenheimer; Deming Mi; Melinda E Sanders; Richard M Caprioli
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

5.  Expression of p53, Ki-67 and c-Myc proteins is predictive of the surgical molecular margin in colorectal carcinoma.

Authors:  Nan Li; Jingmei Wang; Shanshan Shen; Xiaodong Bu; Xiaoqiang Tian; Peilin Huang
Journal:  Pathol Oncol Res       Date:  2011-02-05       Impact factor: 3.201

6.  Rapid Intraoperative Molecular Characterization of Glioma.

Authors:  Ganesh M Shankar; Joshua M Francis; Mikael L Rinne; Shakti H Ramkissoon; Franklin W Huang; Andrew S Venteicher; Elliot H Akama-Garren; Yun Jee Kang; Nina Lelic; James C Kim; Loreal E Brown; Sarah K Charbonneau; Alexandra J Golby; Chandra Sekhar Pedamallu; Mai P Hoang; Ryan J Sullivan; Andrew D Cherniack; Levi A Garraway; Anat Stemmer-Rachamimov; David A Reardon; Patrick Y Wen; Priscilla K Brastianos; William T Curry; Fred G Barker; William C Hahn; Brian V Nahed; Keith L Ligon; David N Louis; Daniel P Cahill; Matthew Meyerson
Journal:  JAMA Oncol       Date:  2015-08       Impact factor: 31.777

7.  The value of diffusion-weighted imaging in assessing the ADC changes of tissues adjacent to breast carcinoma.

Authors:  Zhang Yili; Huang Xiaoyan; Du Hongwen; Zhang Yun; Chen Xin; Wang Peng; Guo Youmin
Journal:  BMC Cancer       Date:  2009-01-14       Impact factor: 4.430

8.  Optimal margins for early stage peripheral lung adenocarcinoma resection.

Authors:  Pan Yin; Bingqing Yue; Ji Zhang; Dong Liu; Dongyu Bai; Guang Zhao; Chutong Huang; Guojun Geng; Jie Jiang; Yongxiang Su; Xiuyi Yu; Jingyu Chen
Journal:  BMC Cancer       Date:  2021-05-11       Impact factor: 4.430

9.  NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal.

Authors:  Sun Och Yoon; Eun Kyung Kim; Mira Lee; Woon Yong Jung; Hyunjoo Lee; Youngran Kang; You-Jin Jang; Soon Won Hong; Seung Ho Choi; Woo Ick Yang
Journal:  Oncotarget       Date:  2016-01-19

10.  Prognostic value of molecular events from negative surgical margin of non-small-cell lung cancer.

Authors:  Bangrong Cao; Lin Feng; Dan Lu; Yan Liu; Yu Liu; Suping Guo; Naijun Han; Xiangyang Liu; Yousheng Mao; Jie He; Shujun Cheng; Yanning Gao; Kaitai Zhang
Journal:  Oncotarget       Date:  2016-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.